menu search

Sagimet biosciences to present at the h.c. wainwright 7th annual nash investor conference

SAN MATEO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical...

October 18, 2023, 4:05 pm

Evelo (evlo) drops 59% on flunking psoriasis drug study

Evelo's (EVLO) EDP2939 fails to achieve the primary endpoint in a mid-stage for treating moderate psoriasis. The company decides to cease ...

October 18, 2023, 12:47 pm

Nkarta (nktx) rallies 112% as fda clears ind for lupus drug

Nkarta (NKTX) rallies 112% on FDA nod to begin the clinical development of its investigational candidat...

October 18, 2023, 12:03 pm

Hookipa pharma announces publication of preclinical data of hepatitis b virus (hbv) therapeutic vaccine developed in collaboration with gilead sciences

HB-400, a novel arenaviral therapeutic vaccine, generates robust T cell responses specific to hepatitis B virus with high antibody levels in a pre...

October 18, 2023, 11:01 am

Why is viking therapeutics (vktx) stock moving today?

Viking Therapeutics (NASDAQ: VKTX ) stock is on the move Wednesday as the clinical-stage biopharmaceuti...

October 18, 2023, 10:01 am

Sage therapeutics jump 5% on huntington's drug call by fda

Shares of Sage Therapeutics Inc jumped 5% in premarket trading following the announcement that the US Food and Drug Administration (FDA) has granted...

October 18, 2023, 7:41 am

Astrazeneca leads ftse fallers with no obvious reason

AstraZeneca PLC (LSE:AZN) shares were the biggest faller on the FTSE 100 on Wednesday, down 3.6%, with no obvious reason for the sell-off.  News and...

October 18, 2023, 7:19 am

Stock movers: united airlines shares drop after warning on fuel costs and middle east conflict

Shares of Viking Therapeutics Inc. VKTX, -0.37% rallied nearly 11% following early clinical study data ...

October 18, 2023, 5:57 am

Scancell to speak at prestigious vaccine event

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing immunotherapies for cancer and infectious disease, said its chief executive and chie...

October 18, 2023, 3:14 am

Cyclarity therapeutics announces clinical advisory board

NOVATO, Calif, Oct. 17, 2023 (GLOBE NEWSWIRE) — Cyclarity Therapeutics, Inc. (https://cyclaritytx.com), today announced its newly formed ...

October 17, 2023, 10:04 pm

Viking therapeutics' stock rallies following early drug study data

Viking Therapeutics Inc. VKTX, -0.37% shares rose in the extended session Tuesday after the biotech drug developer said data from an early stage ...

October 17, 2023, 4:56 pm

Oric pharmaceuticals to present initial phase 1b clinical data for oric 114 in egfr/her2 exon 20 mutated nsclc at the european society of medical oncology (esmo) congress 2023

Company to host a conference call and webcast on Saturday, October 21, 2023, at 9:00 am ET featuring Dr. Alexander Spira to discuss initial data and p...

October 17, 2023, 4:30 pm

Philips (phg) aids clinicians with new monitoring solution

Philips (PHG) launches Visual Patient Avatar to help anesthesiologists with situational awareness in operating rooms, boosting their ...

October 17, 2023, 12:46 pm

Preclinical data demonstrate anti-siglec-15 treatment reduced bone loss and enhanced bone quality in mice with moderate-to-severe osteogenesis imperfecta (oi)

Data Presented at the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting BELTSVILLE, Md., Oct. 17, 2023 (GLOBE NEWSWIRE) — N...

October 17, 2023, 12:05 pm

Sellas life sciences to present final data from phase 1/2 study of galinpepimut-s in combination with keytruda® (pembrolizumab) in patients with wt1+ platinum-resistant advanced ovarian cancer at the

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS'' or the “Company”), a late-stage ...

October 17, 2023, 8:45 am

Zymeworks to host third quarter 2023 results conference call

VANCOUVER, British Columbia, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical...

October 17, 2023, 8:30 am

Neurobo to present at the h.c. wainwright 7th annual nash investor conference

BOSTON , Oct. 17, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage b...

October 17, 2023, 8:01 am

89bio to participate in the h.c. wainwright 7ᵗʰ annual nash investor conference

SAN FRANCISCO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharma...

October 17, 2023, 8:00 am

Apollomics announces presentations of vebreltinib data at esmo 2023

FOSTER CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (the “Company”), a late-stage ...

October 16, 2023, 10:55 pm

Sava stock continues to plunge on misconduct allegations

Big problems appear to be getting worse for Cassava Sciences (NASDAQ: SAVA ). The clinical-stage biotec...

October 16, 2023, 5:26 pm


Search within

Pages Search Results: